These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19804440)

  • 1. Efficacy of omalizumab in delayed pressure urticaria: a case report.
    Bindslev-Jensen C; Skov PS
    Allergy; 2010 Jan; 65(1):138-9. PubMed ID: 19804440
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic autoimmune urticaria with omalizumab.
    Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of omalizumab on patients with chronic urticaria: issues with the determination of autoimmune urticaria.
    Sheikh J
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):88; author reply 88-9. PubMed ID: 18254490
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of omalizumab in cholinergic urticaria.
    Sabroe RA
    Clin Exp Dermatol; 2010 Jun; 35(4):e127-9. PubMed ID: 19925484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema.
    Dreyfus DH
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):624-5. PubMed ID: 18592835
    [No Abstract]   [Full Text] [Related]  

  • 6. Omalizumab as a therapeutic alternative for chronic urticaria.
    Callejas-Rubio JL; Sánchez-Cano D; Lara MA; Ortego-Centeno N
    Ann Allergy Asthma Immunol; 2008 Nov; 101(5):556. PubMed ID: 19055216
    [No Abstract]   [Full Text] [Related]  

  • 7. Partial improvement of solar urticaria after omalizumab.
    Waibel KH; Reese DA; Hamilton RG; Devillez RL
    J Allergy Clin Immunol; 2010 Feb; 125(2):490-1. PubMed ID: 20159260
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria.
    Metz M; Altrichter S; Ardelean E; Kessler B; Krause K; Magerl M; Siebenhaar F; Weller K; Zuberbier T; Maurer M
    Int Arch Allergy Immunol; 2011; 154(2):177-80. PubMed ID: 20733327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omalizumab also successful in chronic urticaria.
    Spector SL; Tan RA
    J Allergy Clin Immunol; 2008 Mar; 121(3):784; author reply 784-5. PubMed ID: 18328900
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test.
    Rodríguez-Trabado A; Fernández Pereira LM; Romero-Chala S; García-Trujillo JA; Cámara Hijón C
    Allergol Immunopathol (Madr); 2012; 40(6):390-2. PubMed ID: 22178123
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective treatment of refractory severe heat urticaria with omalizumab.
    Bullerkotte U; Wieczorek D; Kapp A; Wedi B
    Allergy; 2010 Jul; 65(7):931-2. PubMed ID: 19930230
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of solar urticaria with anti-immunoglobulin E therapy.
    Güzelbey O; Ardelean E; Magerl M; Zuberbier T; Maurer M; Metz M
    Allergy; 2008 Nov; 63(11):1563-5. PubMed ID: 18925897
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic alternatives for chronic urticaria: additional reports on omalizumab.
    Spector SL; Tan RA
    Ann Allergy Asthma Immunol; 2008 Dec; 101(6):647. PubMed ID: 19119713
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological effects of omalizumab in chronic urticaria: a case report.
    Iemoli E; Piconi S; Fusi A; Borgonovo L; Borelli M; Trabattoni D
    J Investig Allergol Clin Immunol; 2010; 20(3):252-4. PubMed ID: 20635791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab is effective in nonautoimmune urticaria.
    Ferrer M; Gamboa P; Sanz ML; Goikoetxea MJ; Cabrera-Freitag P; Javaloyes G; Berroa F; Kaplan AP
    J Allergy Clin Immunol; 2011 May; 127(5):1300-2. PubMed ID: 21315432
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab.
    Magerl M; Staubach P; Altrichter S; Ardelean E; Krause K; Metz M; Weller K; Maurer M
    J Allergy Clin Immunol; 2010 Sep; 126(3):665-6. PubMed ID: 20673981
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic autoimmune urticaria: treatment with omalizumab].
    Máspero JF; Parisi CA; De Gennaro M; Benhabib O; Lampert M
    Arch Argent Pediatr; 2009 Oct; 107(5):452-6. PubMed ID: 19809768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
    Lin H; Boesel KM; Griffith DT; Prussin C; Foster B; Romero FA; Townley R; Casale TB
    J Allergy Clin Immunol; 2004 Feb; 113(2):297-302. PubMed ID: 14767445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.
    Geller M
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic urticaria resistant to H1 antihistamines].
    Guinnepain MT
    Ann Dermatol Venereol; 2003 May; 130 Spec No 1():1S78-85. PubMed ID: 12843813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.